Overall, these results show that a 3-month clinical intervention with L-GSH supplementation in T2DM subjects resulted in significantly decreased levels of the proinflammatory cytokine IL-6, and a decrease in the oxidative stress marker MDA
Front Plant Sci 10(2):117
Supply Chain Security and Regulatory Navigation When you make complicated peptides, gaps are less likely when you have long-term supply deals
has received grants from Sanofi and consultancy, speaker fees or travel support from Advicciene, Astellas, AstraZeneca, Amicus, Amgen, Fresenius Medical Care, GSK, Bayer, Sanofi-Genzyme, Menarini, Kyowa Kirin, Alexion, Idorsia, Chiesi, Otsuka, Novo-Nordisk and Vifor Fresenius Medical Care Renal Pharma, and is the Director of the Catedra Mundipharma-UAM for diabetic kidney disease and the Catedra Astrazeneca-UAM for chronic kidney disease and electrolytes